Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (NDUFA10), is an accessory subunit of mitochondrial complex I (NADH:ubiquinone oxidoreductase), which is the first and largest enzyme of the mitochondrial respiratory electron transport chain. NDUFA10 is believed not to be directly involved in catalysis but is required for proper complex I assembly or stability. Its principal function is part of the multi-protein machinery that transfers electrons from NADH to ubiquinone, coupled to proton translocation, driving ATP synthesis by oxidative phosphorylation. Mutations in NDUFA10 have been implicated in severe mitochondrial disorders, including Leigh syndrome and other forms of mitochondrial complex I deficiency.
For the overall complex: facilitation of electron transfer from NADH to ubiquinone, contributing to oxidative phosphorylation; NDUFA10 itself believed to be an accessory subunit not directly involved in catalysis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (NDUFA10).